Eastgate Biotech Corp Probability of Future Stock Price Finishing Over 0.0045
| ETBIDelisted Stock | USD 0 0.00 0.00% |
Eastgate |
Eastgate Biotech Target Price Odds to finish over 0.0045
The tendency of Eastgate Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0 | 90 days | 0 | about 63.15 |
Based on a normal probability distribution, the odds of Eastgate Biotech to move above the current price in 90 days from now is about 63.15 (This Eastgate Biotech Corp probability density function shows the probability of Eastgate Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Eastgate Biotech Corp has a beta of -45.73 suggesting as returns on its benchmark rise, returns on holding Eastgate Biotech Corp are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Eastgate Biotech is expected to outperform its benchmark. In addition to that Eastgate Biotech Corp has an alpha of 69.6525, implying that it can generate a 69.65 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Eastgate Biotech Price Density |
| Price |
Predictive Modules for Eastgate Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Eastgate Biotech Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Eastgate Biotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Eastgate Biotech is not an exception. The market had few large corrections towards the Eastgate Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Eastgate Biotech Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Eastgate Biotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 69.65 | |
β | Beta against Dow Jones | -45.73 | |
σ | Overall volatility | 0 | |
Ir | Information ratio | 0.12 |
Eastgate Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Eastgate Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Eastgate Biotech Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Eastgate Biotech is not yet fully synchronised with the market data | |
| Eastgate Biotech has some characteristics of a very speculative penny stock | |
| Eastgate Biotech has a very high chance of going through financial distress in the upcoming years | |
| Eastgate Biotech Corp currently holds 1.67 M in liabilities. Eastgate Biotech Corp has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Eastgate Biotech's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (2.98 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Eastgate Biotech Corp currently holds about 4.91 K in cash with (389.48 K) of positive cash flow from operations. |
Eastgate Biotech Technical Analysis
Eastgate Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Eastgate Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Eastgate Biotech Corp. In general, you should focus on analyzing Eastgate Stock price patterns and their correlations with different microeconomic environments and drivers.
Eastgate Biotech Predictive Forecast Models
Eastgate Biotech's time-series forecasting models is one of many Eastgate Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Eastgate Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Eastgate Biotech Corp
Checking the ongoing alerts about Eastgate Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Eastgate Biotech Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Eastgate Biotech is not yet fully synchronised with the market data | |
| Eastgate Biotech has some characteristics of a very speculative penny stock | |
| Eastgate Biotech has a very high chance of going through financial distress in the upcoming years | |
| Eastgate Biotech Corp currently holds 1.67 M in liabilities. Eastgate Biotech Corp has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Eastgate Biotech's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (2.98 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Eastgate Biotech Corp currently holds about 4.91 K in cash with (389.48 K) of positive cash flow from operations. |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Eastgate Stock
If you are still planning to invest in Eastgate Biotech Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eastgate Biotech's history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |